Volenrelaxin

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameVolenrelaxin
Drug Alias NameRelaxin-LALY-3540378
ClassificationBiologics
Mechanisms of ActionRelaxin replacementsRelaxin receptor 1 agonists
TargetsRelaxin receptor 1
Therapy Area/IndicationsHeart Failure, DiastolicHeart FailureRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[14
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsHeart Failure, DiastolicHeart FailureRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A